Viking Therapeutics: Phase 3 Obesity Data Feels Like A Coin Toss (Rating Downgrade) [Seeking Alpha]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Seeking Alpha
VKTX's $700m cash position supports ongoing trials, regulatory submission, and potential commercialization, bolstered by a new manufacturing agreement and commercial leadership. VK2735's early efficacy and safety data are promising but derived from small cohorts; larger Phase 3 studies are needed to validate competitive differentiation. I downgrade VKTX from Buy to Hold due to intensifying competition and binary Phase 3 risk, advising investors to await Q3 Phase 1 maintenance data. Looking for a helping hand in the market? Members of Haggerston BioHealth get exclusive ideas and guidance to navigate any climate. Learn More » Chip Simons/Stockbyte via Getty Images Investment Overview I last updated on Viking Therapeutics, Inc. ( VKTX ) in October last year, covering the company's Q3 earnings and business updates, and issued stock with a Buy rating - my sixth straight Buy call, in fact, following notes More on my IG service If you are interested in keeping up to date wit
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment [Yahoo! Finance]Yahoo! Finance
- Why Is Viking Therapeutics (VKTX) Up 16.3% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Is Viking Therapeutics (VKTX) Price Move Justified By DCF And Book Value Signals [Yahoo! Finance]Yahoo! Finance
- Here's Why Viking Therapeutics Stock Recovered and Can Soar in 2026 [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (VKTX) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 3/10/26 - Form 4
- 2/11/26 - Form 10-K
- 2/11/26 - Form 8-K
- VKTX's page on the SEC website